Italia markets close in 5 hours 17 minutes
FTSE MIB
34.926,77 -472,05 (-1,33%) Dow Jones
40.003,59 +134,19 (+0,34%) Nasdaq
16.685,97 -12,33 (-0,07%) Nikkei 225
39.069,68 +282,30 (+0,73%) Petrolio
79,79 -0,27 (-0,34%) Bitcoin EUR
61.647,80 -163,43 (-0,26%)
Trulieve Cannabis Corp. (TCNNF)
Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 03:59PM EDT
| Chiusura precedente | 12,48 |
| Aperto | 12,88 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 12,25 - 12,88 |
| Intervallo di 52 settimane | 3,42 - 14,50 |
| Volume | |
| Media Volume | 539.869 |
| Capitalizzazione | 2,301B |
| Beta (5 anni mensile) | 1,46 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -2,26 |
| Prossima data utili | 07 ago 2024 - 12 ago 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 17,70 |
GlobeNewswireCytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
PRINCETON, N.J., July 19, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the appointment of Alexander D’Amico as Chief Financial Officer, to begin employment on August 7, 2023. Mr. D’Amico brings over 20 years of broad finance, SEC reporting, merger and acquisition, fundraising, and account
© 2024 Yahoo. Tutti i diritti riservati.